Contractor
AVKARE LLC
- UEI
- SFPGXE6XPS93
- Parent UEI
- UGC4CXE71LM4
- Resolved by
- uei
- Confidence
- 1.000
Active from Jun 30, 2025 to Aug 6, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79725D0046 NEW AWARD FOR EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS WITH AVKARE, LLC. BASE YEAR ORDERING PERIOD IS OCTOBER 6, 2025 TO OCTOBER 5, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Jun 30, 2025 | — |
| 36F79723D0144 PRICE DECREASE | Department of Veterans Affairs | — | Mar 3, 2026 | — |
| 36E79726D0036 AWARDED TO AVKARE LLC FOR FAMCICLOVIR TABLETS FOR THE BASE YEAR WITH FOUR ONE YEAR OPTIONS. | Department of Veterans Affairs | — | Jul 20, 2026 | — |
| 36E79722D0015 EXERCISE OPTION 4 WITH NO PRICE CHANGES | Department of Veterans Affairs | — | Jul 9, 2026 | — |
| 36E79722D0025 EXERCISE THE FOURTH OPTION YEAR FOR ACETAZOLAMIDE TABLETS, CONTRACT 36E79722D0025, WITH AVKARE, LLC WITH NO PRICE CHANGES. | Department of Veterans Affairs | — | Jun 23, 2026 | — |
| 36E79725D0027 MYCOPHENOLATE OPTION YEAR 1 WITH AVKARE, LLC WITH NO PRICE CHANGES | Department of Veterans Affairs | — | Jun 16, 2026 | — |
| 36E79726D0031 NEW AWARD FOR MONTELUKAST NA CHEWABLE TABLETS WITH AVKARE LLC. ORDERING PERIOD IS AUGUST 9, 2026 TO AUGUST 8, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | May 18, 2026 | — |
| SPE2D326F089W 4571706825!VENLAFAXINE HCL ER 75 MG CAP 90S | Department of Defense | TN | May 4, 2026 | $5 |
| SPE2D226D0007 4610132772! | Department of Defense | — | Mar 5, 2026 | — |
| SPE2D326F087N 4571706828!NALOXONE HCL 4 MG NASAL SPRAY 2S | Department of Defense | TN | May 4, 2026 | $46 |
| 36E79724D0029 EXCERCISE OPTION YEAR 2 FOR AVKARE CONTRACT 36E79724D0029 FOR TENOFOVIR WITH NO PRICE CHANGES | Department of Veterans Affairs | — | May 1, 2026 | — |
| SPE2D326F072B 4571665411!SULFAMETHOXAZOLE-TMP DS TABLET 100S | Department of Defense | TN | Apr 29, 2026 | $1,476 |
| SPE2D326F070G 4571659146!SULFAMETHOXAZOLE-TMP DS TABLET 100S | Department of Defense | TN | Apr 29, 2026 | $295 |
| SPE2D326F066N 4571649536!BENZONATATE 100 MG CAPSULE 100S | Department of Defense | TN | Apr 28, 2026 | $12 |
| SPE2D225D0013 4610121118! | Department of Defense | — | Apr 28, 2026 | — |
| SPE2D326F066W 4571649534!EMTRICITABINE-TENOFV 200-300MG UU 30S | Department of Defense | TN | Apr 28, 2026 | $44 |
| SPE2D326F067Q 4571649537!BENZONATATE 100 MG CAPSULE 100S | Department of Defense | TN | Apr 28, 2026 | $24 |
| SPE2D326F058R 4571612130!EMTRICITABINE-TENOFV 200-300MG UU 30S | Department of Defense | TN | Apr 24, 2026 | $44 |
| SPE2D326F053P 4571593534!SULFAMETHOXAZOLE-TMP DS TABLET 100S | Department of Defense | TN | Apr 23, 2026 | $738 |
| SPE2D326F057V 4571624609!NALOXONE HCL 4 MG NASAL SPRAY 2S | Department of Defense | TN | Apr 23, 2026 | $138 |
| SPE2D326F056P 4571593536!EMTRICITABINE-TENOFV 200-300MG UU 30S | Department of Defense | TN | Apr 23, 2026 | $1,090 |
| SPE2D326F051T 4571584920!NALOXONE HCL 4 MG NASAL SPRAY 2S | Department of Defense | TN | Apr 22, 2026 | $138 |
| SPE2D326F051V 4571584921!BENZONATATE 100 MG CAPSULE 100S | Department of Defense | TN | Apr 22, 2026 | $6 |
| SPE2D326F051E 4571577877!BENZONATATE 100 MG CAPSULE 100S | Department of Defense | TN | Apr 22, 2026 | $6 |
| SPE2D326F043P 4571574825!FAMCICLOVIR 125 MG TABLET 30S | Department of Defense | TN | Apr 21, 2026 | $33 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier SFPGXE6XPS93, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.